Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891836-05-000247
Filing Date
2005-04-28
Accepted
2005-04-28 16:56:39
Documents
1
Group Members
ANDREW H. TISCHBENJAMIN TISCHDANIEL R. TISCHJAMES S. TISCHJESSICA S. TISCHMERRYL H. TISCHTHOMAS M. STEINBERG

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 sc0115.htm SC 13D/A 65299
  Complete submission text file 0000891836-05-000247.txt   67421
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45279 | Film No.: 05781360
SIC: 2834 Pharmaceutical Preparations

Mailing Address 667 MADISON AVE NEW YORK NY 10021
Business Address C/O B.L. BLOOM 667 MADISON AVENUE NEW YORK NY 10021 2127521850
TISCH THOMAS J (Filed by) CIK: 0001081916 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A